EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer’s Disease

Daniel A Bolívar iD, María I Mosquera-Heredia iD, Oscar M Vidal iD, Ernesto Barceló, Ricardo Allegri, Luis C Morales, Carlos Silvera-Redondo, Mauricio Arcos-Burgos, Pilar Garavito-Galofre, Jorge I Vélez iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Daniel A Bolívar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial Engineering, Universidad del Norte, Barranquilla 081007, Colombia. Hauptthemen laut MEDLINE: Alzheimer Disease, RNA, Messenger, Biomarkers, Exosomes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministery of Science, Technology and Innovation of Colombia (MINCIENCIAS), Ministry of Science, Technology and Innovation of Colombia (MINCIENCIAS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and memory loss. While the precise causes of AD remain unclear, emerging evidence suggests that messenger RNA (mRNA) dysregulation contributes to AD pathology and risk. This study examined exosomal mRNA expression profiles of 15 individuals diagnosed with AD and 15 healthy controls from Barranquilla, Colombia. Utilizing advanced bioinformatics and machine learning (ML) techniques, we identified differentially expressed mRNAs and assessed their predictive power for AD diagnosis and AD age of onset (ADAOO). Our results showed that ENST00000331581 (CADM1) and ENST00000382258 (TNFRSF19) were significantly upregulated in AD patients. Key predictors for AD diagnosis included ENST00000311550 (GABRB3), ENST00000278765 (GGTLC1), ENST00000331581 (CADM1), ENST00000372572 (FOXJ3), and ENST00000636358 (ACY1), achieving > 90% accuracy in both training and testing datasets. For ADAOO, ENST00000340552 (LIMK2) expression correlated with a delay of ~12.6 years, while ENST00000304677 (RNASE6), ENST00000640218 (HNRNPU), ENST00000602017 (PPP5D1), ENST00000224950 (STN1), and ENST00000322088 (PPP2R1A) emerged as the most important predictors. ENST00000304677 (RNASE6) and ENST00000602017 (PPP5D1) showed promising predictive accuracy in unseen data. These findings suggest that mRNA expression profiles may serve as effective biomarkers for AD diagnosis and ADAOO, providing a cost-efficient and minimally invasive tool for early detection and monitoring. Further research is needed to validate these results in larger, diverse cohorts and explore the biological roles of the identified mRNAs in AD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseRNA, MessengerBiomarkersExosomesAge of OnsetHumansFemaleMaleAgedAged, 80 and overMachine LearningGene Expression ProfilingCase-Control StudiesMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseaseexosomesmRNAmachine learningpersonalized medicine

Substanzen

RNA, MessengerBiomarkers

Autor:innen und Institutionen

  • Department of Industrial Engineering, Universidad del Norte, Barranquilla 081007, Colombia.
  • Department of Medicine, Universidad del Norte, Barranquilla 081007, Colombia.
  • Instituto Colombiano de Neuropedagogía, Barranquilla 080020, Colombia.
  • Department of Health Sciences, Universidad de La Costa, Barranquilla 080002, Colombia.
  • Grupo Internacional de Investigación Neuro-Conductual (GIINCO), Universidad de La Costa, Barranquilla 080002, Colombia.
  • Institute for Neurological Research FLENI, Montañeses 2325, Buenos Aires C1428AQK, Argentina.

ORCID-Profile: Daniel A Bolívar, María I Mosquera-Heredia, Oscar M Vidal, Jorge I Vélez

Förderung

  • Ministery of Science, Technology and Innovation of Colombia (MINCIENCIAS)
  • Ministry of Science, Technology and Innovation of Colombia (MINCIENCIAS)

Zitieren

APA

Bolívar, D. A., Mosquera-Heredia, M. I., Vidal, O. M., Barceló, E., Allegri, R., Morales, L. C., Silvera-Redondo, C., Arcos-Burgos, M., Garavito-Galofre, P., & Vélez, J. I. (2024). Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212293

Vancouver

Bolívar DA, Mosquera-Heredia MI, Vidal OM, Barceló E, Allegri R, Morales LC, et al. Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer’s Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212293

BibTeX
@article{Bolvar2024,
  author = {Bolívar, Daniel A and Mosquera-Heredia, María I and Vidal, Oscar M and Barceló, Ernesto and Allegri, Ricardo and Morales, Luis C and Silvera-Redondo, Carlos and Arcos-Burgos, Mauricio and Garavito-Galofre, Pilar and Vélez, Jorge I},
  title = {Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212293}
}
Kostenlos starten →